Categories AlphaGraphs, Earnings, Health Care

Infographic: Highlights of Gilead Sciences (GILD) Q2 earnings report

Biopharmaceutical company  Gilead Sciences Inc (NASDAQ: GILD) reported its second-quarter 2021 earnings today after the closing bell.

The revenue increased by 21% to $6.2 billion compared to the previous year.

The net income was $1.52 billion or $1.21 per share compared to a loss of $3.3 billion or $2.66 per share of the same quarter in the previous year.

The adjusted earnings per share were $1.87 compared to $1.11 of the previous year.

Most Popular

AAPL Earnings: Apple Q1 revenue up 11%; earnings beat Street view

Apple Inc. (NASDAQ: AAPL) on Thursday said its first-quarter sales and earnings increased, aided by stable demand for its popular smartphone brand iPhone and strength of the services business. The

INTC Stock: Intel set to gain from stable sales, capacity expansion this year

Intel Corporation (NASDAQ: INTC) has been on an aggressive expansion drive to strengthen its foothold in the semiconductor industry. The chipmaker's recent performance indicates it has effectively tackled competition through

Microsoft (MSFT) becomes a compelling buy after strong earnings, Activision deal

Microsoft Corp. (NASDAQ: MSFT) is one of the most innovative technology companies, constantly transforming the business to align with the rapidly changing digital economy. While aggressively participating in the digital

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top